Igor Proscurshim

3.8k total citations · 1 hit paper
47 papers, 2.5k citations indexed

About

Igor Proscurshim is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Igor Proscurshim has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 33 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Igor Proscurshim's work include Colorectal Cancer Surgical Treatments (31 papers), Colorectal and Anal Carcinomas (29 papers) and Colorectal Cancer Screening and Detection (13 papers). Igor Proscurshim is often cited by papers focused on Colorectal Cancer Surgical Treatments (31 papers), Colorectal and Anal Carcinomas (29 papers) and Colorectal Cancer Screening and Detection (13 papers). Igor Proscurshim collaborates with scholars based in Brazil, United States and Belgium. Igor Proscurshim's co-authors include Rodrigo Oliva Perez, Angelita Habr‐Gama, Joaquim Gama‐Rodrigues, Guilherme Pagin São Julião, Desidério Roberto Kiss, Patricio B. Lynn, Wladimir Nadalin, Ivan Cecconello, Charles Sabbagh and Fábio Guilherme Campos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Igor Proscurshim

46 papers receiving 2.5k citations

Hit Papers

Local Recurrence After Complete Clinical Response and Wat... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Local Recurrence After Complete Clinical Response and Watch and Wait in Rectal Cancer After Neoadjuvant Chemoradiation: Impact of Salvage Therapy on Local Disease Control
    2014 366 citations Angelita Habr‐Gama, Joaquim Gama‐Rodrigues et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Proscurshim Brazil 24 2.4k 2.0k 532 280 95 47 2.5k
Dennis A. Wicherts Netherlands 23 2.1k 0.9× 1.2k 0.6× 749 1.4× 210 0.8× 86 0.9× 49 2.7k
Seung Kook Sohn South Korea 20 1.7k 0.7× 1.6k 0.8× 426 0.8× 89 0.3× 60 0.6× 51 2.0k
G Samama France 12 1.0k 0.4× 1.6k 0.8× 928 1.7× 384 1.4× 84 0.9× 51 2.2k
Jeroen W. A. Leijtens Netherlands 17 1.8k 0.8× 1.4k 0.7× 341 0.6× 374 1.3× 77 0.8× 34 2.0k
Suk-Hwan Lee South Korea 18 982 0.4× 957 0.5× 240 0.5× 95 0.3× 111 1.2× 72 1.3k
Brunella Barbaro Italy 30 2.2k 0.9× 1.6k 0.8× 584 1.1× 1.0k 3.7× 87 0.9× 93 3.0k
Jean‐François Gigot Belgium 21 874 0.4× 961 0.5× 508 1.0× 119 0.4× 36 0.4× 54 1.5k
David B. Chessin United States 17 1.0k 0.4× 1.1k 0.5× 237 0.4× 132 0.5× 60 0.6× 30 1.4k
Masanao Kurata Japan 27 968 0.4× 1.2k 0.6× 694 1.3× 118 0.4× 17 0.2× 73 1.8k
Alec McDonald United Kingdom 15 902 0.4× 855 0.4× 565 1.1× 52 0.2× 52 0.5× 30 1.4k

Countries citing papers authored by Igor Proscurshim

Since Specialization
Citations

This map shows the geographic impact of Igor Proscurshim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Proscurshim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Proscurshim more than expected).

Fields of papers citing papers by Igor Proscurshim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Proscurshim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Proscurshim. The network helps show where Igor Proscurshim may publish in the future.

Co-authorship network of co-authors of Igor Proscurshim

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Proscurshim. A scholar is included among the top collaborators of Igor Proscurshim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Proscurshim. Igor Proscurshim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dudek, Arkadiusz Z., Dejan Juric, Afshin Dowlati, et al.. (2021). 476 First-in-human phase 1/2 study of the first-in-class SUMO-activating enzyme inhibitor TAK-981 in patients with advanced or metastatic solid tumors or relapsed/refractory lymphoma: phase 1 results. Regular and Young Investigator Award Abstracts. A505–A506. 10 indexed citations
3.
Habr‐Gama, Angelita, Patricio B. Lynn, José Márcio Neves Jorge, et al.. (2016). Impact of Organ-Preserving Strategies on Anorectal Function in Patients with Distal Rectal Cancer Following Neoadjuvant Chemoradiation. Diseases of the Colon & Rectum. 59(4). 264–269. 91 indexed citations
4.
Perez, Rodrigo Oliva, Angelita Habr‐Gama, Guilherme Pagin São Julião, et al.. (2014). Transanal Local Excision for Distal Rectal Cancer and Incomplete Response to Neoadjuvant Chemoradiation – Does Baseline Staging Matter?. Diseases of the Colon & Rectum. 57(11). 1253–1259. 21 indexed citations
5.
Perez, Rodrigo Oliva, Angelita Habr‐Gama, Guilherme Pagin São Julião, et al.. (2013). Clinical relevance of positron emission tomography/computed tomography‐positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation. Colorectal Disease. 15(6). 674–682. 11 indexed citations
6.
Habr‐Gama, Angelita, Jorge Sabbaga, Joaquim Gama‐Rodrigues, et al.. (2013). Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer. Diseases of the Colon & Rectum. 56(10). 1109–1117. 302 indexed citations
7.
Perez, Rodrigo Oliva, Angelita Habr‐Gama, Patricio B. Lynn, et al.. (2012). Transanal Endoscopic Microsurgery for Residual Rectal Cancer (ypT0-2) Following Neoadjuvant Chemoradiation Therapy. Diseases of the Colon & Rectum. 56(1). 6–13. 94 indexed citations
8.
Perez, Rodrigo Oliva, Angelita Habr‐Gama, Guilherme Pagin São Julião, et al.. (2012). Optimal Timing for Assessment of Tumor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer: Do All Patients Benefit From Waiting Longer Than 6 Weeks?. International Journal of Radiation Oncology*Biology*Physics. 84(5). 1159–1165. 53 indexed citations
9.
Perez, Rodrigo Oliva, Angelita Habr‐Gama, Patricio B. Lynn, et al.. (2011). Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer?. Colorectal Disease. 14(6). 714–720. 90 indexed citations
10.
Perez, Rodrigo Oliva, Angelita Habr‐Gama, Joaquim Gama‐Rodrigues, et al.. (2011). Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation. Cancer. 118(14). 3501–3511. 85 indexed citations
11.
Habr‐Gama, Angelita, Rodrigo Oliva Perez, Guilherme Pagin São Julião, Igor Proscurshim, & Joaquim Gama‐Rodrigues. (2010). The need for effective radiosentitizing agents. Anti-Cancer Drugs. 22(4). 308–310. 8 indexed citations
12.
Perez, Rodrigo Oliva, Guilherme Pagin São Julião, Angelita Habr‐Gama, et al.. (2009). The Role of Carcinoembriogenic Antigen in Predicting Response and Survival to Neoadjuvant Chemoradiotherapy for Distal Rectal Cancer. Diseases of the Colon & Rectum. 52(6). 1137–1143. 90 indexed citations
13.
Habr‐Gama, Angelita, Rodrigo Oliva Perez, Igor Proscurshim, et al.. (2008). Absence of Lymph Nodes in the Resected Specimen After Radical Surgery for Distal Rectal Cancer and Neoadjuvant Chemoradiation Therapy: What does it Mean?. Diseases of the Colon & Rectum. 51(3). 277–283. 73 indexed citations
14.
Perez, Rodrigo Oliva, Cláudio José Caldas Bresciani, Igor Proscurshim, et al.. (2008). Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis. International Journal of Colorectal Disease. 23(8). 757–765. 38 indexed citations
15.
Habr‐Gama, Angelita, Rodrigo Oliva Perez, Igor Proscurshim, et al.. (2008). Interval Between Surgery and Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Does Delayed Surgery Have an Impact on Outcome?. International Journal of Radiation Oncology*Biology*Physics. 71(4). 1181–1188. 151 indexed citations
16.
Perez, Rodrigo Oliva, Angelita Habr‐Gama, Igor Proscurshim, et al.. (2007). Local Excision for ypT2 Rectal Cancer—Much Ado About Something. Journal of Gastrointestinal Surgery. 11(11). 1431–1440. 37 indexed citations
17.
Perez, Rodrigo Oliva, et al.. (2007). Endoscopic management of postoperative stapled colorectal anastomosis hemorrhage. Techniques in Coloproctology. 11(1). 64–6. 24 indexed citations
18.
Perez, Rodrigo Oliva, Angelita Habr‐Gama, Rafael Miyashiro, et al.. (2007). Peritumoral Inflammatory Infiltrate is not a Prognostic Factor in Distal Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Journal of Gastrointestinal Surgery. 11(11). 1534–1540. 11 indexed citations
19.
Habr‐Gama, Angelita, Rodrigo Oliva Perez, Igor Proscurshim, et al.. (2006). Patterns of Failure and Survival for Nonoperative Treatment of Stage c0 Distal Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. Journal of Gastrointestinal Surgery. 10(10). 1319–1329. 269 indexed citations
20.
Perez, Rodrigo Oliva, Angelita Habr‐Gama, Carlos Eduardo Jacob, et al.. (2005). Laparoscopic Versus Standard Appendectomy Outcomes and Cost Comparisons in the Private Sector. Journal of Gastrointestinal Surgery. 9(8). 1174–1181. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis A. Wicherts Breakdown of academic impact, for papers by Seung Kook Sohn Breakdown of academic impact, for papers by G Samama Breakdown of academic impact, for papers by Jeroen W. A. Leijtens Breakdown of academic impact, for papers by Suk-Hwan Lee Breakdown of academic impact, for papers by Brunella Barbaro Breakdown of academic impact, for papers by Jean‐François Gigot Breakdown of academic impact, for papers by David B. Chessin Breakdown of academic impact, for papers by Masanao Kurata Breakdown of academic impact, for papers by Alec McDonald
Rankless by CCL
2026